TTR and polyneuropathy: Transthyretin tetramer stabilization was confirmed also upon oral treatment with tafamidis meglumine 20 mg once daily in patients with ATTRv with polyneuropathy and mutations other than Val30Met in 100% of evaluable patients [103].